Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-02

FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Eugia US LLC)

View source ↗

Summary

FDA approved a supplemental application for pantoprazole sodium from Eugia US LLC, adding a regulatory change to an existing pantoprazole product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pantoprazole sodium (pantoprazole sodium)

Snippet

SUPPL AP for PANTOPRAZOLE SODIUM (PANTOPRAZOLE SODIUM)